Pressure BioSciences, Inc. (PBIO) Reports Q2 Loss of $0.57
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts PBIO Hot Sheet
Price: $0.00 --0%
Financial Fact:
Warrant income relating to revaluation: 623.13K
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Warrant income relating to revaluation: 623.13K
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Pressure BioSciences, Inc. (OTC: PBIO) reported Q2 EPS of ($0.57), versus $0.00 reported last year. Revenue for the quarter came in at $510 thousand.
For earnings history and earnings-related data on Pressure BioSciences, Inc. (PBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
- Frontline stock hits 52-week high on oil price surge
- Helen of Troy (HELE) Tops Q2 EPS by 28c, Misses on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
